X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (50) 50
oncology (46) 46
humans (45) 45
female (36) 36
middle aged (27) 27
aged (26) 26
male (24) 24
adult (21) 21
cancer (16) 16
colorectal cancer (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
chemotherapy (13) 13
prognosis (12) 12
tumors (11) 11
therapy (10) 10
aged, 80 and over (9) 9
antineoplastic agents - therapeutic use (9) 9
animals (8) 8
lung neoplasms - drug therapy (8) 8
treatment outcome (8) 8
care and treatment (7) 7
disease-free survival (7) 7
drug administration schedule (7) 7
mice (7) 7
mutation (7) 7
neoplasm staging (7) 7
neoplasms - pathology (7) 7
receptor, epidermal growth factor - genetics (7) 7
chemotherapy, adjuvant (6) 6
genetic aspects (6) 6
health aspects (6) 6
human necessities (6) 6
hygiene (6) 6
italy (6) 6
medical or veterinary science (6) 6
metastasis (6) 6
neoplasms - drug therapy (6) 6
preparations for medical, dental, or toilet purposes (6) 6
survival rate (6) 6
5-fluorouracil (5) 5
adenocarcinoma (5) 5
carcinoma, non-small-cell lung - drug therapy (5) 5
carcinoma, non-small-cell lung - mortality (5) 5
colorectal neoplasms - drug therapy (5) 5
colorectal neoplasms - genetics (5) 5
drug therapy (5) 5
fluorouracil - administration & dosage (5) 5
hematology, oncology and palliative medicine (5) 5
lung neoplasms - mortality (5) 5
research (5) 5
acquired-resistance (4) 4
adjuvant treatment (4) 4
administration, oral (4) 4
adolescent (4) 4
analysis (4) 4
antineoplastic agents - pharmacology (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
breast cancer (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
cell biology (4) 4
cetuximab (4) 4
clinical trials (4) 4
clinical trials as topic (4) 4
colonic neoplasms - drug therapy (4) 4
colorectal neoplasms - metabolism (4) 4
deoxyribonucleic acid--dna (4) 4
dose-response relationship, drug (4) 4
drug resistance, neoplasm - genetics (4) 4
fluorouracil (4) 4
follow-up studies (4) 4
lung neoplasms - genetics (4) 4
molecular targeted therapy (4) 4
ovarian neoplasms - drug therapy (4) 4
ovarian neoplasms - pathology (4) 4
pharmacokinetics (4) 4
proto-oncogene proteins p21 - genetics (4) 4
receptor, epidermal growth factor - antagonists & inhibitors (4) 4
receptor, erbb-2 - genetics (4) 4
salvage therapy (4) 4
young adult (4) 4
1st-line treatment (3) 3
antibodies, monoclonal, humanized (3) 3
biochemistry & molecular biology (3) 3
biomarkers (3) 3
breast (3) 3
cancer therapies (3) 3
cancer-patients (3) 3
carcinoma (3) 3
colon (3) 3
colon cancer (3) 3
colonic neoplasms - mortality (3) 3
colonic neoplasms - pathology (3) 3
colorectal neoplasms - pathology (3) 3
colorectal-cancer (3) 3
combined modality therapy (3) 3
dna mutational analysis (3) 3
drug resistance, neoplasm - drug effects (3) 3
erlotinib (3) 3
folinic acid (3) 3
gene copy number (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Journal Article
Nature Medicine, ISSN 1078-8956, 07/2015, Volume 21, Issue 7, pp. 795 - 801
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 2011, Volume 103, Issue 11, pp. 863 - 875
Background Approximately 15% of colorectal cancers develop because of defective function of the DNA mismatch repair (MMR) system. We determined the association... 
ISLAND METHYLATOR PHENOTYPE | ONCOLOGY | NONPOLYPOSIS COLORECTAL-CANCER | PROGNOSIS | LYNCH SYNDROME | MICROSATELLITE-INSTABILITY | FLUOROURACIL | CARCINOMA | EXPRESSION | CHEMOTHERAPY | LEVAMISOLE | Multivariate Analysis | MutL Protein Homolog 1 | Predictive Value of Tests | Recurrence | Colonic Neoplasms - genetics | Microsatellite Instability | Prognosis | Humans | Middle Aged | Male | Colonic Neoplasms - surgery | Fluorouracil - administration & dosage | DNA Mismatch Repair | Aged, 80 and over | Germ-Line Mutation | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Chemotherapy, Adjuvant | Nuclear Proteins - genetics | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Proportional Hazards Models | MutS Homolog 2 Protein - genetics | DNA-Binding Proteins - genetics | Adenocarcinoma - secondary | Randomized Controlled Trials as Topic | Disease-Free Survival | Adenocarcinoma - therapy | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Adaptor Proteins, Signal Transducing - genetics | Survival Analysis | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Colon cancer | Adjuvant treatment | Development and progression | Research | Drug therapy | Health aspects | DNA mismatch repair | Cancer | Polymerase chain reaction | Clinical trials | DNA repair | Deoxyribonucleic acid--DNA | Colorectal cancer | 5-Fluorouracil | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 263 - 267
Colorectal cancer is the third most common cancer worldwide, with 1.2 million patients diagnosed annually. In late-stage colorectal cancer, the most commonly... 
PANITUMUMAB | THERAPY | MULTIDISCIPLINARY SCIENCES | SEQUENCE | ACQUIRED-RESISTANCE | SOMATIC MUTATION | IDENTIFICATION | GENE COPY NUMBER | ACTIVATING MUTATIONS | BREAST | INSIGHTS | Receptor, Epidermal Growth Factor - genetics | Receptor, ErbB-2 - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Colorectal Neoplasms - genetics | Genomics | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Molecular Targeted Therapy | Receptor, Fibroblast Growth Factor, Type 1 - genetics | MAP Kinase Kinase 1 - genetics | Colorectal Neoplasms - drug therapy | Female | Antineoplastic Agents - pharmacology | Insulin Receptor Substrate Proteins - genetics | Colorectal Neoplasms - metabolism | Antibodies, Monoclonal - pharmacology | Cetuximab - pharmacology | DNA Copy Number Variations - genetics | Mutation - genetics | Genome, Human - genetics | Receptor, Epidermal Growth Factor - chemistry | Xenograft Model Antitumor Assays | Drug Resistance, Neoplasm - genetics | Exome - genetics | Animals | Receptor, Platelet-Derived Growth Factor alpha - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Drug Resistance, Neoplasm - drug effects | Care and treatment | Gene mutations | Colorectal cancer | Drug metabolism | Genetic aspects | Identification and classification | Health aspects | Proteins | Epidermal growth factor | Genes | Clinical trials | Mutation | Kinases | Cancer therapies | Tumors | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 2017, Volume 552, Issue 7683, pp. 1 - 5
Journal Article
Seminars in Oncology, ISSN 0093-7754, 2001, Volume 28, Issue 1, pp. 14 - 19
Journal Article
Modern Pathology, ISSN 0893-3952, 11/2015, Volume 28, Issue 11, pp. 1481 - 1491
Journal Article
Journal Article